Back to News
Market Impact: 0.15

VIG ETF Factor Report

VIGNDAQ
Company FundamentalsAnalyst InsightsHealthcare & BiotechTechnology & InnovationMarket Technicals & Flows
VIG        ETF Factor Report

Validea's fundamental report indicates the Vanguard Dividend Appreciation ETF (VIG) is a large-cap quality ETF with significant exposure to the quality (score of 96) and low volatility (score of 91) factors. The ETF's portfolio is heavily weighted in the Technology sector, with Biotechnology & Drugs as the largest industry. Its exposure to value and momentum factors is moderate, with scores of 40 and 52, respectively.

Analysis

Validea's fundamental report characterizes the Vanguard Dividend Appreciation ETF (VIG) as a Large-Cap Quality ETF, underscored by an exceptionally high Quality factor score of 96 out of 99 and a robust Low Volatility score of 91. This profile indicates a strong orientation towards companies with sound fundamentals and historically stable price behavior. The analysis reveals VIG's largest sectoral allocation is to Technology, with Biotechnology & Drugs constituting the largest industry exposure. Conversely, the ETF's engagement with Value and Momentum factors is moderate, scoring 40 and 52 respectively, suggesting a less aggressive posture in these dimensions. The provided sentiment for VIG is positive (0.5), contributing to an overall mildly positive sentiment for the report, though the market impact is assessed as low. This composition aligns with an investment strategy focused on consistent dividend growth from established, high-caliber enterprises.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.20

Ticker Sentiment

NDAQ0.00
VIG0.50

Key Decisions for Investors

  • Consider VIG for core portfolio allocations if seeking exposure to large-cap, high-quality equities with an emphasis on lower volatility and consistent dividend growth.
  • Monitor the concentration in Technology and Biotechnology & Drugs sectors, as these can introduce specific risks and return drivers despite the ETF's overall quality and low volatility characteristics.
  • Recognize that VIG's moderate scores in Value and Momentum may lead to differentiated performance during market phases strongly driven by these specific factors, and investors might look to complement this holding if broader factor exposure is desired.